Brenden Rearick

Brenden Rearick

InvestorPlace Financial News Writer

Expertise: Blockchain, Cryptocurrency, Digital Asset Regulation

Education: BA, Public & Professional Writing and Political Science, University of Pittsburgh

About Brenden:
Brenden Rearick is a Financial News Writer for the Today’s Market team at InvestorPlace, joining the team in 2021. Before joining InvestorPlace, Brenden was a student and a freelance writer, contributing to various periodicals for the University of Pittsburgh and local non-profits.

He primarily covers cryptocurrency and blockchain technology for Today’s Market. His interests span the metaverse, as well as DeFi and Web 3.0 projects.

You can follow Brenden on Twitter.

Recent Articles

AMC Starts Accepting Dogecoin for Giftcards After DOGE Prices Skyrocket

By Brenden Rearick, InvestorPlace Financial News Writer

AMC starts accepting Dogecoin today, and shareholders are surely quite happy. Adam Aron is beginning the long crypto payment rollout process.

CEI Stock and 4 Other Big Names Kerrisdale Capital Has Sold Short

By Brenden Rearick, InvestorPlace Financial News Writer

CEI stock is the target of Kerrisdale's newest short position. Camber Energy joins the ranks of many other meme plays with the news.

Cardano Price Predictions: Why Grayscale Thinks ADA Looks ‘Undervalued’

By Brenden Rearick, InvestorPlace Financial News Writer

Cardano price predictions are heating up as Grayscale calls the ADA coin 'undervalued' when compared to the blockchain network giant Ethereum.

Ripple Lawsuit News: Judge Delivers a Blow to Devoted XRP Crypto Fans

By Brenden Rearick, InvestorPlace Financial News Writer

The latest piece of Ripple lawsuit news is a blow to the XRP ledger. A judge is denying XRP holders from testifying on behalf of the network.

OCGN Stock: 2 Huge Reasons Ocugen Stock Is Shooting Higher Today

By Brenden Rearick, InvestorPlace Financial News Writer

OCGN stock is surging on some big news. The World Health Organization could give the company the go-ahead on its Covid-19 vaccine very soon.

Load More